Double Medical Technology Inc. (SHE:002901)
China · Delayed Price · Currency is CNY 40.68
+0.10 (0.25%)
Nov 13, 2026, 3:04 PM CST
Double Medical Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 911.66 | 1,222 | 1,076 | 1,228 | 992.67 | 410.19 |
Short-Term Investments | 30.41 | 30.35 | - | - | - | 41.3 |
Trading Asset Securities | 597.88 | 496.97 | 172.75 | 433.2 | 358.67 | 769.71 |
Cash & Short-Term Investments | 1,540 | 1,749 | 1,249 | 1,661 | 1,351 | 1,221 |
Cash Growth | 14.31% | 40.10% | -24.83% | 22.92% | 10.66% | 11.29% |
Accounts Receivable | 321.66 | 302.87 | 235.67 | 242.52 | 324.97 | 457.99 |
Other Receivables | 9.91 | 13.3 | 9.87 | 10.46 | 8.75 | 9.79 |
Receivables | 331.57 | 316.17 | 245.54 | 252.97 | 333.72 | 467.77 |
Inventory | 1,367 | 1,235 | 1,273 | 1,193 | 987.35 | 670.15 |
Other Current Assets | 54.81 | 38.88 | 44.6 | 48.06 | 53.79 | 35.97 |
Total Current Assets | 3,294 | 3,339 | 2,812 | 3,155 | 2,726 | 2,395 |
Property, Plant & Equipment | 1,155 | 1,194 | 1,193 | 1,071 | 877.68 | 698.72 |
Long-Term Investments | - | - | - | - | - | 1.33 |
Goodwill | 65.55 | 61.86 | 67.77 | 68.27 | 69.13 | 69.68 |
Other Intangible Assets | 118.65 | 116.93 | 125.61 | 136.92 | 143.16 | 148.59 |
Long-Term Deferred Tax Assets | 13.08 | 11.38 | 14.43 | 8.93 | 7.04 | 8.26 |
Long-Term Deferred Charges | 189.76 | 196.64 | 203.1 | 197.49 | 109.61 | 57.27 |
Other Long-Term Assets | 3.03 | 4.19 | 2.95 | 1.93 | 4.69 | 0.9 |
Total Assets | 4,839 | 4,924 | 4,419 | 4,640 | 3,938 | 3,380 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 258.21 | 266.64 | 253.32 | 281.64 | 345.36 | 296.3 |
Accrued Expenses | 121.57 | 169.24 | 157 | 128.41 | 107.16 | 131.39 |
Short-Term Debt | - | 2.47 | 80.75 | 316.84 | 0.59 | 2.41 |
Current Portion of Long-Term Debt | 29.67 | 5.29 | 50.63 | 2.88 | 1.4 | - |
Current Portion of Leases | - | 7.08 | 6.01 | 8.27 | 6.32 | 5.04 |
Current Income Taxes Payable | 47.26 | 27.69 | 20.59 | 4.93 | 11.5 | 45.58 |
Current Unearned Revenue | 128.84 | 132.03 | 118.95 | 171.94 | 136.96 | 58.48 |
Other Current Liabilities | 268.57 | 267.76 | 254.15 | 238.81 | 107.31 | 182.59 |
Total Current Liabilities | 854.12 | 878.18 | 941.4 | 1,154 | 716.6 | 721.78 |
Long-Term Debt | 273.59 | 296.03 | 243.67 | 261.32 | 47.96 | - |
Long-Term Leases | 3.23 | 5.01 | 4.63 | 10.88 | 12.9 | 13.61 |
Long-Term Unearned Revenue | 48.53 | 55.84 | 45.51 | 50.13 | 48.68 | 48.51 |
Long-Term Deferred Tax Liabilities | 0.57 | 1.13 | 2.11 | 3.08 | 5.01 | 7.57 |
Other Long-Term Liabilities | - | 2.8 | - | - | - | - |
Total Liabilities | 1,180 | 1,239 | 1,237 | 1,479 | 831.15 | 791.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 414.02 | 414.02 | 414.02 | 414.02 | 414.02 | 405.14 |
Additional Paid-In Capital | 1,155 | 1,130 | 1,104 | 1,102 | 1,102 | 594.23 |
Retained Earnings | 2,425 | 2,197 | 1,800 | 1,547 | 1,488 | 1,605 |
Treasury Stock | -426.6 | -166.61 | -234.98 | - | - | -89.79 |
Comprehensive Income & Other | -4.64 | -4.16 | -4.31 | -4.25 | -4.05 | -1.66 |
Total Common Equity | 3,563 | 3,570 | 3,079 | 3,058 | 3,000 | 2,512 |
Minority Interest | 96 | 115.24 | 102.62 | 102.16 | 106.65 | 75.91 |
Shareholders' Equity | 3,659 | 3,685 | 3,182 | 3,161 | 3,106 | 2,588 |
Total Liabilities & Equity | 4,839 | 4,924 | 4,419 | 4,640 | 3,938 | 3,380 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | 306.48 | 315.87 | 385.68 | 600.2 | 69.17 | 21.06 |
Net Cash (Debt) | 1,233 | 1,434 | 863.01 | 1,061 | 1,282 | 1,200 |
Net Cash Growth | 17.09% | 66.11% | -18.65% | -17.26% | 6.83% | 9.37% |
Net Cash Per Share | 3.01 | 3.51 | 2.08 | 2.52 | 3.05 | 2.98 |
Filing Date Shares Outstanding | 402.55 | 408.77 | 406.61 | 414.02 | 414.02 | 401.23 |
Total Common Shares Outstanding | 402.55 | 408.77 | 406.61 | 414.02 | 414.02 | 401.23 |
Working Capital | 2,440 | 2,461 | 1,870 | 2,002 | 2,010 | 1,673 |
Book Value Per Share | 8.85 | 8.73 | 7.57 | 7.39 | 7.25 | 6.26 |
Tangible Book Value | 3,379 | 3,391 | 2,886 | 2,853 | 2,787 | 2,294 |
Tangible Book Value Per Share | 8.39 | 8.30 | 7.10 | 6.89 | 6.73 | 5.72 |
Buildings | - | 756.38 | 730.83 | 409.91 | 324.68 | 315.79 |
Machinery | - | 911.22 | 865.43 | 805.97 | 736.92 | 552.66 |
Construction In Progress | - | 117.37 | 80.24 | 238.25 | 113.1 | 51.56 |